NO742557L - - Google Patents
Info
- Publication number
- NO742557L NO742557L NO742557A NO742557A NO742557L NO 742557 L NO742557 L NO 742557L NO 742557 A NO742557 A NO 742557A NO 742557 A NO742557 A NO 742557A NO 742557 L NO742557 L NO 742557L
- Authority
- NO
- Norway
- Prior art keywords
- poultry
- vaccine
- disease
- marek
- pathogenic
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 claims description 58
- 239000000463 material Substances 0.000 claims description 34
- 208000006758 Marek Disease Diseases 0.000 claims description 30
- 244000144977 poultry Species 0.000 claims description 28
- 241000700605 Viruses Species 0.000 claims description 25
- 230000001717 pathogenic effect Effects 0.000 claims description 25
- 238000012546 transfer Methods 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 16
- 210000001161 mammalian embryo Anatomy 0.000 claims description 11
- 230000002163 immunogen Effects 0.000 claims description 8
- 210000001325 yolk sac Anatomy 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 230000003053 immunization Effects 0.000 claims description 5
- 230000001605 fetal effect Effects 0.000 claims description 4
- 210000002257 embryonic structure Anatomy 0.000 claims description 3
- 238000002649 immunization Methods 0.000 claims description 3
- 238000000338 in vitro Methods 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 2
- 238000011161 development Methods 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 230000015788 innate immune response Effects 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 206010011224 Cough Diseases 0.000 claims 1
- 238000009395 breeding Methods 0.000 claims 1
- 230000001488 breeding effect Effects 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 description 40
- 235000013330 chicken meat Nutrition 0.000 description 36
- 235000013594 poultry meat Nutrition 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 19
- 208000015181 infectious disease Diseases 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 11
- 238000002255 vaccination Methods 0.000 description 11
- 241000271566 Aves Species 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000036039 immunity Effects 0.000 description 8
- 230000003472 neutralizing effect Effects 0.000 description 8
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 244000144992 flock Species 0.000 description 6
- 230000028993 immune response Effects 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 230000005875 antibody response Effects 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 206010010356 Congenital anomaly Diseases 0.000 description 4
- 210000003754 fetus Anatomy 0.000 description 4
- 210000000265 leukocyte Anatomy 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 206010058874 Viraemia Diseases 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 241001493065 dsRNA viruses Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 238000003307 slaughter Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- JDRAOGVAQOVDEB-KTKRTIGZSA-N (3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl) (z)-octadec-9-enoate Chemical compound OC1COC2C(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC21 JDRAOGVAQOVDEB-KTKRTIGZSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 1
- 206010025282 Lymphoedema Diseases 0.000 description 1
- 241001502481 Meleagrid alphaherpesvirus 1 Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 208000002502 lymphedema Diseases 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 231100001160 nonlethal Toxicity 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38061573A | 1973-07-19 | 1973-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO742557L true NO742557L (fi) | 1975-02-17 |
Family
ID=23501855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO742557A NO742557L (fi) | 1973-07-19 | 1974-07-12 |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5052227A (fi) |
| AR (1) | AR201878A1 (fi) |
| AT (1) | AT346476B (fi) |
| AU (1) | AU7096274A (fi) |
| BE (1) | BE817865A (fi) |
| DE (1) | DE2434515A1 (fi) |
| DK (1) | DK137931B (fi) |
| ES (1) | ES428370A1 (fi) |
| FI (1) | FI219974A (fi) |
| FR (1) | FR2301268A1 (fi) |
| GB (1) | GB1481847A (fi) |
| IE (1) | IE40159B1 (fi) |
| IL (1) | IL45181A0 (fi) |
| IT (1) | IT1017330B (fi) |
| NL (1) | NL7409842A (fi) |
| NO (1) | NO742557L (fi) |
| SE (1) | SE7409411L (fi) |
| ZA (1) | ZA743771B (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU197517B (en) * | 1984-07-30 | 1989-04-28 | Laszlo Csatary | Process for production of terapeutical composition applicable against virus infection |
| JPS6327437A (ja) * | 1986-07-17 | 1988-02-05 | Chemo Sero Therapeut Res Inst | 鶏伝染病生ワクチン |
| CN114717200B (zh) * | 2022-03-16 | 2023-03-24 | 河南省农业科学院 | 一株马立克病病毒特超强毒株及其基因缺失毒株的构建和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1941373B1 (de) * | 1969-08-14 | 1970-11-19 | Lohmann & Co Kg | Verfahren zur Herstellung einer Lebendvakzine gegen die Mareksche Krankheit der Huehner |
| JPS5013333B1 (fi) * | 1970-04-22 | 1975-05-19 |
-
1974
- 1974-06-13 ZA ZA00743771A patent/ZA743771B/xx unknown
- 1974-07-03 IL IL45181A patent/IL45181A0/xx unknown
- 1974-07-08 AU AU70962/74A patent/AU7096274A/en not_active Expired
- 1974-07-12 NO NO742557A patent/NO742557L/no unknown
- 1974-07-17 GB GB31643/74A patent/GB1481847A/en not_active Expired
- 1974-07-17 ES ES428370A patent/ES428370A1/es not_active Expired
- 1974-07-18 DE DE2434515A patent/DE2434515A1/de not_active Ceased
- 1974-07-18 SE SE7409411A patent/SE7409411L/xx unknown
- 1974-07-18 FI FI2199/74A patent/FI219974A/fi unknown
- 1974-07-19 JP JP49083133A patent/JPS5052227A/ja active Pending
- 1974-07-19 NL NL7409842A patent/NL7409842A/xx not_active Application Discontinuation
- 1974-07-19 IE IE1538/74A patent/IE40159B1/xx unknown
- 1974-07-19 BE BE146746A patent/BE817865A/xx unknown
- 1974-07-19 DK DK389574AA patent/DK137931B/da unknown
- 1974-07-19 FR FR7425174A patent/FR2301268A1/fr active Granted
- 1974-07-19 IT IT25410/74A patent/IT1017330B/it active
- 1974-07-19 AT AT600274A patent/AT346476B/de not_active IP Right Cessation
- 1974-07-19 AR AR254792A patent/AR201878A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| NL7409842A (nl) | 1975-01-21 |
| ZA743771B (en) | 1975-07-30 |
| SE7409411L (fi) | 1975-01-20 |
| BE817865A (fr) | 1974-11-18 |
| JPS5052227A (fi) | 1975-05-09 |
| IL45181A0 (en) | 1974-10-22 |
| ES428370A1 (es) | 1976-09-16 |
| AR201878A1 (es) | 1975-04-24 |
| FR2301268B1 (fi) | 1978-07-21 |
| FI219974A (fi) | 1975-01-20 |
| IT1017330B (it) | 1977-07-20 |
| AT346476B (de) | 1978-11-10 |
| ATA600274A (de) | 1978-03-15 |
| IE40159B1 (en) | 1979-03-28 |
| DE2434515A1 (de) | 1975-03-27 |
| FR2301268A1 (fr) | 1976-09-17 |
| IE40159L (en) | 1975-01-19 |
| DK137931C (fi) | 1978-10-30 |
| DK137931B (da) | 1978-06-05 |
| AU7096274A (en) | 1976-01-08 |
| GB1481847A (en) | 1977-08-03 |
| DK389574A (fi) | 1975-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4438097A (en) | Coccidiosis vaccines | |
| US4530831A (en) | Infectious Bursal Disease vaccine | |
| US4009259A (en) | Immersion method for treating aquatic animals | |
| US7462479B2 (en) | Infectious bronchitis virus vaccine | |
| DK179542B1 (en) | Fish vaccine | |
| Horton-Smith et al. | Behavior of invasive stages of Eimeria tenella in the immune fowl (Gallus domesticus) | |
| US4505892A (en) | Infectious bronchitis vaccine for poultry | |
| Rehmani | Newcastle disease vaccination: A comparison of vaccines and routes of administration in Pakistan | |
| NO159782B (no) | Anordning ved fjaersystem, foerst og fremst paa kjoeretoeyer. | |
| HU183765B (en) | Process for producing lyophilized vaccine against duck hepatitis | |
| US3981771A (en) | Marek's disease vaccine | |
| NO742557L (fi) | ||
| KR0127116B1 (ko) | 전염성 점액낭 질병의 예방을 위한 왁찐 | |
| JP3945842B2 (ja) | 弱毒性ニューカッスル病ウイルスワクチン | |
| KR20000069501A (ko) | 뉴우캐슬병에 대한 난내 백신화 | |
| US3479430A (en) | Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same | |
| Evelyn et al. | Laboratory and field observations on antivibriosis vaccines | |
| US3548054A (en) | Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease | |
| KR101092977B1 (ko) | 닭전염성 기관지염 바이러스 및 이를 포함하는 닭전염성 기관지염 백신 | |
| DK202170436A1 (en) | Sea Lice Vaccines | |
| CN109576230B (zh) | 一株禽脑脊髓炎病毒毒株及其应用 | |
| US3585108A (en) | Transmissible gastroenteritis vaccines and methods of producing the same | |
| EP0107845A2 (en) | Vaccine for immunizing cattle against infectious bovine keratoconjunctivitis by Moraxella Bovis | |
| DK202070286A1 (en) | IgY antibodies for the prevention of sea lice infestation and infection | |
| US3704203A (en) | Transmissible gastroenteritis vaccines and methods of producing the same |